Escalon Medical Corp.
ESMC
$0.19
-$0.02-9.52%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 34.24% | 4.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 34.24% | 4.09% | |||
| Cost of Revenue | 30.93% | 7.51% | |||
| Gross Profit | 38.85% | -0.29% | |||
| SG&A Expenses | 19.75% | -8.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.35% | -2.17% | |||
| Operating Income | 148.67% | 45.45% | |||
| Income Before Tax | 140.73% | 36.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 140.73% | 36.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 140.73% | 36.84% | |||
| EBIT | 148.67% | 45.45% | |||
| EBITDA | 155.09% | 46.42% | |||
| EPS Basic | 117.30% | -23.10% | |||
| Normalized Basic EPS | 140.59% | 36.88% | |||
| EPS Diluted | 117.30% | -18.40% | |||
| Normalized Diluted EPS | 120.79% | 36.88% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 94.51% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||